🇺🇸 FDA
Patent

US 11555057

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

granted A61KA61K31/495A61K38/00

Quick answer

US patent 11555057 (Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5) held by The Regents of the University of California expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/495, A61K38/00, A61K38/1709, A61P